SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-080917
Filing Date
2023-07-13
Accepted
2023-07-13 21:03:14
Documents
2
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2321276-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2321276-4_3seq1.xml 3 10309
2 EXHIBIT 24 tm2321276d4_ex24.htm EX-24 8200
  Complete submission text file 0001104659-23-080917.txt   19978
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Issuer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SAGIMET BIOSCIENCES INC. 155 BOVET RD., STE. 303 SAN MATEO CA 94402
Business Address
Kemble George (Reporting) CIK: 0001858176 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41742 | Film No.: 231087840